206. Deputy Aengus Ó Snodaigh asked the Minister for Health the reason the recent breakthrough drug available in Britain to cystic fibrosis sufferers is not being made available here; and his views on the Health Service Executive's approach to addressing the shortfall in services and facilities to help cystic fibrosis sufferers here. [4899/13]

askedIreland· Dáil Éireann· EN

Introduced

31 January 2013

Last action

31 January 2013 · Medicinal Products Expenditure

Status

written

Summary

206. Deputy Aengus Ó Snodaigh asked the Minister for Health the reason the recent breakthrough drug available in Britain to cystic fibrosis sufferers is not being made available here; and his views on the Health Service Executive's approach to addressing the shortfall in services and facilities to help cystic fibrosis sufferers here. [4899/13]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

31 January 2013
Medicinal Products Expenditure
206. Deputy Aengus Ó Snodaigh asked the Minister for Health the reason the recent breakthrough drug available in Britain to cystic fibrosis sufferers is not being made available here; and his views on the Health Service Executive's approach to addressing the shortfall in services and facilities to help cystic fibrosis sufferers here. [4899/13]
Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Medicinal Products Expenditure

View file Download file

Medicinal Products Expenditure
xml · EN · 31 January 2013
View Download Open at official source

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.oireachtas.ie/en/debates/question/2013-01-31/206/
Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2013-01-31/pq_206
ireland · q-2013-01-31-pq_206 · source updated 31 January 2013